NR-V04

N/A

Report date: 2023/09/22 17:39:31
NME

Base Information

Drug NameNR-V04
Drug Alias NameNR-V04NR-V-04
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionNuclear receptor subfamily 4 group A member 1 degraders
TargetsNuclear receptor subfamily 4 group A member 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A